recombinant human ctla4 ig fc (R&D Systems)
94
Structured Review
R&D Systems
recombinant human ctla4 ig fc
Recombinant Human Ctla4 Ig Fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+ctla+4+fc/Recombinant+Human+CTLA-4+Fc+Chimera+His-tag+Protein/us12569592-1762-0-3
Average 94 stars, based on 7 article reviews
Recombinant Human Ctla4 Ig Fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+ctla+4+fc/Recombinant+Human+CTLA-4+Fc+Chimera+His-tag+Protein/us12569592-1762-0-3
Average 94 stars, based on 7 article reviews
recombinant human ctla4 ig fc - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Recombinant:Article Title: Anti-CTLA-4 antibodies and methods of use thereof Article Snippet: Briefly, 25 μl of each dilution was incubated in the dark (20° C., 650 rpm) with 1500 Luminex® microspheres in 5 μl assay buffer for 1 hour in 96 half-well filter plates (Millipore, MABVN1250). .. Luminex® microspheres were coupled with Article Title: Lack of blocking activity in anti-CTLA-4 antibodies reduces toxicity, but not anti-tumor efficacy Article Snippet: Data analysis was performed using the Softmax Pro (Molecular Devices, San Jose, CA, USA) or Prism (GraphPad, San Diego, CA, USA) software packages. .. ELISA plates (Nunc, MaxiSorp ELISA plates, flat bottom, uncoated, BioLegend, San Diego, CA, USA) were coated with recombinant Article Title: Anti-CTLA-4 antibodies and methods of use thereof Article Snippet: Briefly, 25 μl of each dilution was incubated in the dark (20° C., 650 rpm) with 1500 Luminex® microspheres in 5 μl assay buffer for 1 hour in 96 half-well filter plates (Millipore, MABVN1250). .. Luminex® microspheres were coupled with Produced:Article Title: Anti-CTLA-4 antibodies and methods of use thereof Article Snippet: Briefly, 25 μl of each dilution was incubated in the dark (20° C., 650 rpm) with 1500 Luminex® microspheres in 5 μl assay buffer for 1 hour in 96 half-well filter plates (Millipore, MABVN1250). .. Luminex® microspheres were coupled with Article Title: Anti-CTLA-4 antibodies and methods of use thereof Article Snippet: Briefly, 25 μl of each dilution was incubated in the dark (20° C., 650 rpm) with 1500 Luminex® microspheres in 5 μl assay buffer for 1 hour in 96 half-well filter plates (Millipore, MABVN1250). .. Luminex® microspheres were coupled with Enzyme-linked Immunosorbent Assay:Article Title: Lack of blocking activity in anti-CTLA-4 antibodies reduces toxicity, but not anti-tumor efficacy Article Snippet: Data analysis was performed using the Softmax Pro (Molecular Devices, San Jose, CA, USA) or Prism (GraphPad, San Diego, CA, USA) software packages. .. ELISA plates (Nunc, MaxiSorp ELISA plates, flat bottom, uncoated, BioLegend, San Diego, CA, USA) were coated with recombinant Article Title: Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8 + T cell immunity to reject ‘cold’ tumors Article Snippet: .. For ligand blocking ELISA, purified Article Title: Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8 + T cell immunity to reject ‘cold’ tumors Article Snippet: .. For antibody binding ELISA, purified Blocking Assay:Article Title: Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8 + T cell immunity to reject ‘cold’ tumors Article Snippet: .. For ligand blocking ELISA, purified Purification:Article Title: Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8 + T cell immunity to reject ‘cold’ tumors Article Snippet: .. For ligand blocking ELISA, purified Article Title: Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8 + T cell immunity to reject ‘cold’ tumors Article Snippet: .. For antibody binding ELISA, purified Binding Assay:Article Title: Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8 + T cell immunity to reject ‘cold’ tumors Article Snippet: .. For antibody binding ELISA, purified |